AgNOR increase in buccal epithelial cells of trisomy 21 infants

Micron

Volumn 39, Issue 8, 2008, Pages 1262-1265

  Yilmaz, Seçil Ilhan ^a   Demirtas, Halil ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

AgNORs; Buccal oral epithelium; Down's syndrome; NORs; Trisomy 21

Indexed keywords

BIOCHEMICAL ENGINEERING; BIOCHEMISTRY; CHROMOSOMES; CYTOLOGY; DIELECTRIC RELAXATION; GENES; HEALTH; IMAGE ANALYSIS; IMAGING TECHNIQUES; PAINTING;

AGNORS; BUCCAL/ORAL EPITHELIUM; CENTRAL NERVOUS SYSTEM; COMPUTER PROGRAMS; DOWN SYNDROMES; DOWN'S SYNDROME; EPITHELIAL CELLS; EXPECTED VALUES; EXPRESSION LEVELS; HEALTHY CONTROLS; NORS; RRNA GENES; STAINING INTENSITY; TRISOMY 21;

CELLS;

RIBOSOME DNA;

ARTICLE; CHEEK; CHILD; CHROMOSOME NOR; DOWN SYNDROME; HUMAN; INFANT; MOUTH MUCOSA; NEWBORN; PRESCHOOL CHILD; ULTRASTRUCTURE;

CHEEK; CHILD; CHILD, PRESCHOOL; DNA, RIBOSOMAL; DOWN SYNDROME; HUMANS; INFANT; INFANT, NEWBORN; MOUTH MUCOSA; NUCLEOLUS ORGANIZER REGION;

EID: 52049106844     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2008.03.014     Document Type: Article

References (37)

1. Antonarakis S.E., and Epstein C.J. The challenge of Down syndrome. Trends Mol. Med. 12 (2006) 473-479
2. Arora B., Kumar S., and Jain R. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions. J. Indian Med. Assoc. 104 1 (2006) 16-18
3. Caburet S., Conti C., Schurra C., Lebofsky R., Edelstein S.J., and Bensimon A. Human ribosomal RNA gene arrays display a broad range of palindromic structures. Genome Res. 15 (2005) 1079-1085
4. Cheon M.S., Shim K.S., Kim S.H., Hara A., and Lubec G. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part IV). Amino Acids 25 (2003) 41-47
5. Cucer N., Imamoglu N., Tozak H., Demirtas H., Sarac F., Tatlisen A., and Oztürk F. Two-dimensional AgNOR evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total AgNOR area/nucleus area per cell. Micron 38 6 (2007) 674-679
6. Demirtas H., Imamoglu N., Donmez H., Cucer N., Yilmaz A., and Candemir Z. Condensed chromatin surface and NORs surface enhancement in mitogen-stimulated lymphocytes of Down syndrome patients. Ann. Genet.-Paris 44 (2001) 77-82
7. Derenzini M., Farabegoli F., Pession A., and Novello F. Spatial redistribution of ribosomal chromatin in the fibrillar centre of human circulating lymphocytes after stimulation of transcription. Exp. Cell Res. 170 (1987) 31-41
8. Derenzini M., and Trerè D. Standardization of interphase Ag-NOR measurement by means of an automated image-analysis system using lymphocytes as an internal control. J. Pathol. 165 4 (1991) 337-342
9. Derenzini M. The AgNORs. Micron 31 2 (2000) 117-120
10. Derenzini M., Ceccarelli C., Santini D., Taffurelli M., and Treré D. The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J. Clin. Pathol. 57 7 (2004) 755-761
11. Deutsch S., Lyle R., Dermitzakis E.T., Subrahmanyan L., Gehrig C., Parand L., Gagnebin M., Rougemont J., Jongeneel C.V., and Antonarakis S.E. Gene expression variation and expression quantitative trait mapping of human chromosome 21 genes. Hum. Mol. Genet. 14 (2005) 3741-3749
12. Giuffrè G., Mormandi F., Barresi V., Bordi C., Tuccari G., and Barresi G. Quantity of AgNORs in gastric endocrine carcinoid tumors as a potential prognostic tool. Eur. J. Histochem. 50 1 (2006) 45-50
13. Greber-Platzer S., Schatzmann-Turhani D., Wollenek G., and Lubec G. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21″ is not overexpressed in hearts of patients with Down syndrome. Biochem. Biophys. Res. Commun. 254 2 (1999) 395-399
14. Guimera J., Casas C., Estivill X., and Pritchard M. Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 57 3 (1999) 407-418
15. Hamurcu Z., Demirtas H., and Kumandas S. Flow cytometric comparison of RNA content in peripheral blood mononuclear cells of Down syndrome patients and control individuals. Cytometry B: Clin. Cytom. 70 (2006) 24-28
16. Hamurcu Z., Demirtas H., Patiroglu T., Kumandas S., Imamoglu N., Ozkul Y., and Donmez-Altuntas H. Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of Down syndrome patients. Cytometry B: Clin. Cytom. 72B (2007) 43-48
17. Hamurcu Z., Demirtas H., Patiroglu T., and Kumandas S. Nuclear protein content in peripheral blood mononuclear cells of trisomy 21 infants. Cytometry B: Clin. Cytom. 74B 2 (2007) 128-132
18. Harris-Cerruti C., Kamsler A., Kaplan B., Lamb B., Segal M., and Groner Y. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein. Eur. J. Neurosci. 19 (2004) 1174-1190
19. Hernandez-Verdun D. The nucleolus: a model for the organization of nuclear functions. Histochem. Cell Biol. 126 (2006) 135-148
20. Hubbell H.R. Silver staining as an indicator of active ribosomal genes. Stain Technol. 60 5 (1985) 285-294
21. Imamoglu N., Demirtas H., Donmez-Altuntas H., and Ilten A. Higher NORs expression in lymphocyte of trisomy 21 babies/children: in vivo evaluation. Micron 36 (2005) 503-507
22. Imamoglu N., Demirtas H., Donmez-Altuntas H., Hamurcu Z., and Ilten A. NOR expression increase on metaphase chromosomes of Down syndrome lymphocytes in concordence with mitogen concentration in culture medium. Cytometry B: Clin. Cytom. 66 (2005) 36-39
23. Imamoglu N., Demirtas H., and Ilten A. NOR expression increases in interphase lymphocytes of Down syndrome babies/children as AgNOR surface, according to the mitogen concentration in the culture medium. Micron 37 (2006) 129-133
24. Jimenez R., and Burgos M. A study of the Ag-staining significance in mitotic NOR's. Heredity 60 (1988) 125-127
25. Kahlem P. Gene-dosage effect on chromosome 21 transcription in trisomy 21: implication in Down syndrome cognitive disorders. Behav. Genet. 36 (2006) 416-428
26. Lindner L.E. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). J. Histochem. Cytochem. 41 (1993) 439-445
27. Mais C., McStay B., and Scheer U. On the formation of amplified nucleoli during early Xenopus oogenesis. J. Struct. Biol. 140 1-3 (2002) 214-226
28. Moore K.L., and Persaud T.V.N. The Developing Human-Clinically Oriented Embryology (The Digestive System). Fifth edition (1993), W.B Saunders Company, Philadelphia p. 237
29. Mrak R.E., and Griffin W.S.T. Trisomy 21 and the brain. J. Neuropathol. Exp. Neurol. 63 (2004) 679-685
30. O'Leary D.A., Pritchard M.A., Xu D., Kola I., Hertzog P.J., and Ristevski S. Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS. Biochim. Biophys. Acta 1739 1 (2004) 81-87
31. Pession A., Farabegoli F., Trere D., Novello F., Montanaro L., Sperti S., Rambelli F., and Derenzini M. The Ag-NOR proteins and transcription and duplication of ribosomal genes in mammalian-cell nucleoli. Chromosoma 100 4 (1991) 242-250
32. Rachidi M., Lopes C., Delezoide A.L., and Delabar J.M. C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome. Cytogenet. Genome Res. 112 1/2 (2006) 16-22
33. Roussel P., and Hernandez-verdun D. Identification of Ag-NOR proteins, markers of proliferation-related to ribosomal gene activity. Exp. Cell Res. 214 2 (1994) 465-472
34. Roussel P., Andre C., Comai L., and HernandezVerdun D. The rDNA transcription machinery is assembled during mitosis in active NORs and absent in inactive NORs. J. Cell Biol. 133 2 (1996) 235-246
35. Sirri V., Roussel P., and Hernandez-Verdun D. The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron 31 (2000) 121-126
36. Trerè D. AgNOR staining and quantification. Micron 31 (2000) 127-131
37. Yilmaz S.I., and Demirtas H. The increase of NORs expression in buccal mucosa cells of Down's syndrome (trisomy 21) infants. Chromosome Res. 15 Suppl. 1 (2007) 86